Vestipitant
From Self-sufficiency
Revision as of 16:32, 30 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): gastrointestinal-drug-, nervous-system-drug-stub)
| 220px | |
| Systematic (IUPAC) name | |
|---|---|
|
(2S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide | |
| Identifiers | |
| CAS Number | 334476-64-1 |
| ATC code | none |
| PubChem | CID 9832383 |
| Chemical data | |
| Formula | C23H21F10N3O |
| Molar mass | 545.416 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Vestipitant is a drug developed by GlaxoSmithKline which acts as a selective antagonist for the NK1 receptor. It is under development as a potential antiemetic and anxiolytic drug,[1][2] and as a treatment for tinnitus.[3]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
| 35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ Reddy GK, Gralla RJ, Hesketh PJ. Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Supportive Cancer Therapy. 2006 Apr 1;3(3):140-2. PMID 18632487
- ↑ Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S, de Nanteuil G, deJong TR, Olivier B, Millan MJ. Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents. European Neuropsychopharmacology. 2008 Oct;18(10):729-50. PMID 18657401
- ↑ ClinicalTrials.gov NCT00394056 Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- NK1 receptor antagonists
- Organofluorides
- Piperazines
- Amides
- Gastrointestinal system drug stubs
- Nervous system drug stubs
